The Atlantic Foundation and its related funds is a family foundation that supports innovators, organizations and programs utilizing innovative approaches to address issues of social justice, environment, and the arts.
BrightEdge is the innovation, impact investment and venture capital arm of the American Cancer Society. Today, our ACS Impact Venture Fund (AIVF) invests in for-profit, early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies to fuel and accelerate ACS’s mission of ending cancer as we know it, for everyone.
